
Journal of Organic Chemistry p. 10088 - 10105 (2013)
Update date:2022-08-15
Topics:
Fer, Mickael J.
Olatunji, Samir
Bouhss, Ahmed
Calvet-Vitale, Sandrine
Gravier-Pelletier, Christine
A straightforward strategy for the synthesis of triazole-containing MraY inhibitors has been developed. It involves the sequential introduction of a terminal alkyne at the 5′ position of an uridine derivative and O-glycosylation with a protected aminoribose leading to an elaborated alkyne scaffold. An efficient Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) allowed the introduction of chemical diversity toward a small library of inhibitors.
View More
Hangzhou Hysen Pharma co.,Ltd.
website:http://www.hysenpharma.cn/
Contact:0086-571-88298791
Address:#701,Gudun Road Hangzhou
Suzhou Ryan Pharmachem Technology Co.,Ltd
Contact:+86-0512-68780025
Address:B-301,No.2 Taishan Road,Suzhou New District,Jiangsu,P.R. China
shanghai jinshan pharmaceutical Co.,Ltd
Contact:021-57363011,13681638167
Address:No. 7966 Tingfeng Road,Jinshan,Shanghai,China
Shijiazhuang City Xiehe Pharmaceutical Co., Ltd
Contact:+86-311-80817929
Address:Shangzhuang,Shijiazhuang,China
ZHUHAI HAIRUIDE BIOSCIENCE AND TECHNOLOGY CO.,LTD
website:http://www.zhhairuide.com
Contact:+8613326687259/+86-756-7789199
Address:No.10 Yonghui Road
Doi:10.1002/ejic.201100725
(2011)Doi:10.1055/s-0034-1378906
(2014)Doi:10.1039/c1ob06216f
(2011)Doi:10.1039/c1ob06345f
(2011)Doi:10.1016/j.saa.2011.08.060
(2012)Doi:10.1007/s11164-011-0447-z
(2012)